A judge has fined two companies for selling garage-door remote controls that infringe three Australian patents owned by U.S.-based The Chamberlain Group.
Corrs Chambers Westgarth has filed a shareholder class action against GetSwift alleging it provided inadequate disclosures and misled investors with its overhyped announcements about business contracts, one month after Squire Patton Boggs brought a similar suit.
Viagogo could calculate from the start of the booking process how much it would charge in booking and handling fees for event tickets, but kept customers in the dark, the ACCC said in a recent court document, rebutting the online ticket reseller’s defense in the consumer regulator’s case.
H.J. Heinz Company Australia Ltd made misleading claims about the health benefits of its Little Kids Shredz products, the Federal Court said Monday. Â
The Australian Stock Exchange has updated rules on company disclosures regarding consumer contracts, in the wake of a share suspension and investor class action against logistics software company GetSwift for “overhyped” business contract announcements.
Squire Patton Boggs has brought a shareholder class action worth potentially $300 million against logistics software company GetSwift and its director, former AFL player Joel MacDonald, for providing inadequate disclosures and misleading investors with âoverhypedâ announcements about business contracts.
The Australian consumer regulator has secured its first penalty in a case brought under the new Franchising Code of Conduct, with a court ordering Pastacup franchisor Morild to pay $100,000 for breaching the code.
Property manager Meriton Property Services violated the law by trying to keep guests at its properties from posting bad reviews on TripAdvisor, the Federal Court said Friday, a win for Australia’s consumer regulator in its first case over online reviews.
The judge overseeing a case brought by Reckitt Benckiser against Aft Pharmaceuticals over its allegedly deceptive painkiller ads has temporarily blocked Aft from releasing ads that claim its Maxigesic painkiller is stronger than other paracetamol-ibuprofen combination drugs.
Aft Pharmaceuticals has denied claims brought by consumer goods giant Reckitt Benckiser that ads for Aft’s over-the-counter painkiller Maxigesic are misleading and causing harm to Reckitt’s brand.